Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
2019
Doulberis, M., Kotronis G., Gialamprinou D., Özgüler O., Exadaktylos A. K., Oikonomou V., et al. (2019).  Acute Liver Failure: From Textbook to Emergency Room and Intensive Care Unit With Concomitant Established and Modern Novel Therapies.. J Clin Gastroenterol. 53(2), 89-101.
Karras, S. N., Polyzos S. A., Tsekmekidou X., Gerou S., Gavana E., Papageorgiou V., et al. (2019).  Adiponectin and vitamin D-binding protein concentrations are independently associated in apparently healthy women but not men: a validation cohort.. Hormones (Athens). 18(1), 99-102.
Polyzos, S. A., Hawa G., Jungwirth T., Karabouta Z., & Kountouras J. (2019).  Asporin levels are low in patients with nonalcoholic fatty liver disease and increase after vitamin E treatment.. Hormones (Athens).
Anastasilakis, D. A., Makras P., Polyzos S. A., & Anastasilakis A. D. (2019).  Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview.. Hormones (Athens). 18(1), 65-70.
Anastasilakis, A. D., Tsourdi E., Makras P., Polyzos S. A., Meier C., McCloskey E. V., et al. (2019).  Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society.. Bone. 127, 401-418.
Polyzos, S. A., & Kountouras J. (2019).  CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis.. Liver Int.
Anastasilakis, A. D., Polyzos S. A., Makras P., Rauner M., Sonnleitner L., Hawa G., et al. (2019).  Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.. J Musculoskelet Neuronal Interact. 19(3), 253-257.
Doulberis, M., Polyzos S. A., Papaefthymiou A., Katsinelos P., & Kountouras J. (2019).  Comments to the Editor concerning the paper entitled "The microbiome and ophthalmic disease" by Baim et al.. Exp Biol Med (Maywood). 244(6), 430-432.
Kountouras, J., Gavalas E., Doulberis M., Polyzos S. A., Papaefthimiou A., Touloumtsi M., et al. (2019).  The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders.. J Neurogastroenterol Motil.
Venetsanaki, V., Karabouta Z., & Polyzos S. A. (2019).  Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis.. Eur J Pharmacol. 863, 172661.
Polyzos, S. A., Perakakis N., & Mantzoros C. S. (2019).  Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.. Metabolism. 96, 66-82.
Anastasilakis, A. D., Koulaxis D., Upadhyay J., Pagkalidou E., Kefala N., Perakakis N., et al. (2019).  Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls.. Horm Metab Res. 51(2), 112-119.
Kountouras, J., Doulberis M., Papaefthimiou A., & Polyzos S. A. (2019).  Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine.. Ann Gastroenterol. 32(3), 318.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Elisabeth V., et al. (2019).  Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection.. Cell Mol Life Sci. 76(13), 2487-2488.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2019).  Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?. Metabolism. 96, iii-v.
Polyzos, S. A., & Kountouras J. (2019).  Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy.. Helicobacter. 24(3), e12588.
Polyzos, S. A., & Kountouras J. (2019).  Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology.. J Clin Gastroenterol.
Kountouras, J., Doulberis M., Polyzos S. A., Katsinelos T., Vardaka E., Kountouras C., et al. (2019).  Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia.. Alzheimers Dement. 15(5), 723-725.
Papaefthymiou, A., Doulberis M., Katsinelos P., Liatsos C., Polyzos S. A., Kotronis G., et al. (2019).  Impact of nitric oxide's bidirectional role on glaucoma: focus on Helicobacter pylori-related nitrosative stress.. Ann N Y Acad Sci.
Papaefthymiou, A., Doulberis M., Kountouras J., Kolokytha C., Galanopoulos M., Liatsos C., et al. (2019).  Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey.. Eur J Gastroenterol Hepatol.
Kountouras, J., Papaefthymiou A., Doulberis M., & Polyzos S. A. (2019).  Influence of Helicobacter pylori-connected metabolic syndrome on non-alcoholic fatty liver disease and its related colorectal neoplasm high risk.. Liver Int.
Anastasilakis, A. D., Polyzos S. A., Makras P., Douni E., & Mantzoros C. S. (2019).  Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?. Metabolism. 93, 100-102.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.